drugset / Trial / NCT02263911
A Study of Baricitinib in Healthy Japanese Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to understand the relationship of 3 different dosage forms of baricitinib. This study will also explore the effect of food on how the body absorbs baricitinib. This study will last about 5 weeks, not including screening. Screening is required within 28 days prior to the date of first dosing.
Timeline
- Start
- 2014-11
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Baricitinib | Small molecule | 4 mg | Oral |
| Subject | Baricitinib | Small molecule | 8 mg | Oral |
Indications
No indication recorded.